Together, these results indicated that the overexpression of USP52 could inhibit cell proliferation of NSCLC, and it was declared that USP52 suppresses NSCLC through the mechanism of inhibiting cell cycle regulatory proteins of CCND1 and CDK2, as well as promoting p53 expression. This evidence concerns the gene TP53 and non-small cell lung carcinoma.